GRM1 and Alzheimer disease: As we previously reported that mGluR1 levels decrease in the human brain frontal cortex with the progression of AD pathology [28], we suggest that mGluR1 levels could depend on the stage of disease and the cellular components (i.e., neurons, glia, etc.)mimicked by the experimental model.